Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers October 31, 2014
Pharmacy Choice - News - Pharmaceutical Industry Trends and Policy - October 31, 2014

Pharmacy News

 Pharmaceutical Industry Trends and Policy
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

10/31/14 - "Crystalline Form of Tiotropium Bromide" in Patent Application Approval Process
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors MEREU, Andrea; MOROSOLI, Moreno; PENNE', Umberto; PERSEGHINI, Mauro, filed on February 25, 2014, was made available online on October 16, 2014, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is
10/31/14 - Axxess Pharma to Sponsor NASCAR's Cole Whitt's Race Car in Sprint Cup Series Race [Food and Beverage Close - Up]
Axxess Pharma said, through its subsidiary AllStar Health Brands, that it will sponsor NASCAR driver Cole Whitt's race car in the November 9 NASCAR Sprint Cup Series Race. For Axxess Pharma, this is the latest promotional venture the company has taken with Nutritional Products International, a Global Sales and Communication firm. "This is a major
10/31/14 - Centric Medical: FDA Clears Tarsa-Link System [Professional Services Close - Up]
Centric Medical reported that the U.S. Food and Drug Administration has given 510 marketing clearance to its Tarsa- Link system, for internal bone fixation of fractures, fusions, and osteotomies in the foot and ankle. According to a release from the company, Tarsa-Link represents a new osteotomy wedge fusion system and joins Centric Medical's suite
10/31/14 - Clovis Oncology: First Patient Enrolled in Lucitanib Phase 2 Study [Professional Services Close - Up]
Clovis Oncology said that its global Phase 2 study of lucitanib in patients with FGFR1-amplified squamous non-small cell lung cancer has commenced and the first patient has been dosed at a U.S. study site. "Less than a year after acquiring lucitanib, we are commencing a broad clinical development program, which includes this study in FGFR1-amplifi
10/31/14 - Dr. Reddy's Debuts Sirolimus Tablets [Health & Beauty Close - Up]
Dr. Reddy's Laboratories reported that it has launched Sirolimus Tablets 1 mg and 2 mg, a therapeutic equivalent generic version of Rapamune tablets in the US market on October 27, following the approval by the United States Food& Drug Administration. According to a company release, Sirolimus tablets in 1 mg and 2 mg are available in bottle counts
10/31/14 - Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In PDL BioPharma, Inc. PDLI To Contact The Firm
By a News Reporter-Staff News Editor at Drug Week Faruqi& Faruqi, LLP, a leading national securities law firm, reminds investors in PDL BioPharma, Inc. of the November 17, 2014 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against PDL and certain executives. A complaint has been filed in the United
10/31/14 - FDA Approves Protein Sciences Flu Vaccine For Older Americans [The Hartford Courant]
Oct. 31 The Food and Drug Administration has extended its approval of the flu vaccine made by Meriden's Protein Sciences to adults age 50 and older. Making the drug available to older people is important for public health, said Protein Sciences Chief Medical Officer Dr. Protein Sciences makes its vaccines using a modern cell culture technology, w
10/31/14 - FDA Clears Tensyn Band for AC/CC Joint Stabilization [Health & Beauty Close - Up]
Dallen Medical reported that the U.S. Food and Drug Administration has granted 510 clearance for its Tensyn Band for acromioclavicular joint and coracoacromial ligament repair in shoulder separation. According to a company release, the Tensyn Band technology, designed for orthopedic surgeons, offers proprietary, knotless banding for stabilized...
10/31/14 - Foundation Medicine and WuXi PharmaTech Partner to Offer Genomic Profiling in China [Professional Services Close - Up]
Foundation Medicine and WuXi PharmaTech reported a collaboration to offer Foundation Medicine's genomic profiling to biopharmaceutical companies conducting clinical trials in China. According to a media release, under the terms of the collaboration, Foundation Medicine will license and enable WuXi to perform the laboratory component of Foundation..
10/31/14 - Generic producers line up as Viagra patent expires [China Daily: Hong Kong Edition]
US pharmaceutical giant Pfizer sold some 300 million doses of Viagra worldwide by 2013. The company applied for the patent in China in 1994 and was granted 20- year exclusive rights in 2001.. There are about 140 million patients with erectile dysfunction in China, according to a report released by Guosen Securities in May. And though its exclusive
10/31/14 - Immunomedics Provides Update On Phase 2 Study Of Isactuzumab Govitecan; Hemispherx Reports New Evidence of Ampligen(R)
{nfg} Immunomedics, Inc., announced isactuzumab govitecan, the Company's proprietary solid-tumor antibody-drug conjugate, continues to produce encouraging results in a Phase 2 clinical trial in heavily-pretreated patients with diverse, metastatic solid cancers. David M. Goldenberg, Chairman, Chief Scientific Officer, and Chief Medical Officer, at t
10/31/14 - Iraq Joins USP Global Program to Assist with Medicine Quality Testing
Release date- 30102014- Rockville, Md.,- The National Center for Drug Control and Research of Iraq is the newest participant in a U.S. Pharmacopeial Convention program designed to assist developing countries improve medicine quality. 'Joining USP's Technical Assistance Program is an important step for increasing Iraq's capacity to ensure the safety
10/31/14 - Iroko Pharmaceuticals to Commercialize Zorvolex [Health & Beauty Close - Up]
Iroko Pharmaceuticals reported that its affiliate, Iroko Pharmaceuticals, signed a licensing agreement with Aspen Pharma, a company incorporated in Australia, for the exclusive rights to register and market Zorvolex capsules in Australia and New Zealand. "The agreement with Aspen Pharma Pty Ltd marks Iroko's sixth international licensing deal this
10/31/14 - La Jolla Pharmaceutical Updates on Data Presentation at the American Society of Nephrology Kidney Week Event [Professional Services Close - Up]
La Jolla Pharmaceutical Company reported that an abstract of the results for the Company's Phase 2 clinical trial of GCS-100 in chronic kidney disease has been selected by the American Society of Nephrology's Program Committee for poster presentation at the Kidney Week Annual Meeting. "We are delighted that results from our Phase 2 study of GCS-10
10/31/14 - Medivation and Astellas Announce Phase 3 Study of Enzalutamide in Men With High-Risk, Hormone-Sensitive, Non-Metastatic Prostate Cancer That Has Recurred Following Definitive Local Therapy
Medivation Inc. and Astellas today announced plans to initiate a global Phase 3 clinical trial that will evaluate the efficacy and safety of enzalutamide in patients with high-risk, hormone-sensitive, non-metastatic prostate cancer that has biochemically recurred following definitive local therapy with radical prostatectomy and/or radiation...
10/31/14 - Nephros Receives FDA 510(k) Clearance for DSU-H and SSU-H Ultrafilters [Professional Services Close - Up]
Nephros reported that the Company has received 510 clearance from the Food and Drug Administration to market its DSU-H and SSU-H Ultrafilters for use in the hospital setting. "The 510 clearance of our DSU-H and SSU-H Ultrafilters represents a significant step forward in helping hospitals and other healthcare facilities with their infection control
10/31/14 - New Market Research Report: Takeda Pharmaceutical Company Limited - Product Pipeline Review - 2014 [ClickPress (UK)]
Global Markets Direct's,' Takeda Pharmaceutical Company Limited- Product Pipeline Review- 2014', provides an overview of the Takeda Pharmaceutical Company Limited's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Takeda Pharmaceutical Company...
10/31/14 - New Toxicology and Pharmacology Study Findings Have Been Reported by Investigators at MHRA (Recommendations from a global cross-company data sharing...
New Toxicology and Pharmacology Study Findings Have Been Reported by Investigators at MHRA. By a News Reporter-Staff News Editor at Drug Week Research findings on Drugs and Therapies are discussed in a new report. According to news reporting from London, United Kingdom, by NewsRx journalists, research stated, "An international expert group which
10/31/14 - Nielsen Catalina Solutions and Crossix Deliver Breakthrough Television Solution for Pharma
By a News Reporter-Staff News Editor at Entertainment Newsweekly Nielsen Catalina Solutions, a leader in behavior-based TV planning and analytics, and Crossix Solutions, the leader in healthcare marketing analytics, have announced a new collaboration that will enable pharma advertisers and their media agencies to improve how they plan and optimiz
10/31/14 - Patent Issued for Natural Product Derivatives with Antiprotozoal Activity
By a News Reporter-Staff News Editor at Drug Week From Alexandria, Virginia, NewsRx journalists report that a patent by the inventor Zhu, Shuren, filed on October 5, 2012, was published online on October 14, 2014. The patent's assignee for patent number 8859578 is Radix Pharmaceuticals, Inc.. It is one of the most common infectious diseases in at
10/31/14 - Patent Issued for Pharmaceutical Formulations of Modafinil
By a News Reporter-Staff News Editor at Health& Medicine Week Cephalon, Inc. has been issued patent number 8859621, according to news reporting originating out of Alexandria, Virginia, by NewsRx editors. The patent's inventors are Heacock, Craig S.; Parikh, Alpa B.; Patel, Piyush R.. This patent was filed on August 21, 2012 and was published onli
10/31/14 - Pharmaceutical and Biopharmaceutical Products Process Validation in the US and EU - Workshop, London, 10-11th February 2015
Dublin- Research and Markets has announced the addition of the "Process Validation in the US and EU" conference to their offering. The Rembrandt Hotel- London, UK. -Science and Risk Based Approach to Process Validation for Pharmaceutical and Biopharmaceutical Products- Quality Risk Management.
10/31/14 - Pozen Gets 3 Patents [Professional Services Close - Up]
Pozen has received three patents from the United States Patent and Trademark Office, titled "Pharmaceutical Compositions for the Coordinated Delivery of NSAIDs" that cover the U.S. approved product VIMOVO delayed-release tablets. "Additionally, these patents demonstrate the continued pattern of innovation by Pozen, which has resulted in 16 issued
10/31/14 - Purdue Pharma, P.F. Laboratories, Purdue Pharmaceuticals Assigned Patent
ALEXANDRIA, Va., Oct. 31 Purdue Pharma, Stamford, Connecticut, P.F. Laboratories, Totowa, New Jersey, and Purdue Pharmaceuticals, Wilson, North Carolina, have been assigned a patent developed by Curtis Wright, Rockport, Massachusetts, Benjamin Oshlack, Boca Raton, Florida, and Christopher Breder, Bethesda, Maryland, for "pharmaceutical formulatio
10/31/14 - Qiagen Enters into Agreement with Astellas Pharma [Health & Beauty Close - Up]
Qiagen has reached a master collaboration agreement with Astellas Pharma to develop and commercialize companion diagnostics paired with Astellas drugs for use in cancer and other diseases. In a release, Qiagen reported that the scope of the agreement is not restricted to certain sample types, platforms, indications or biomarkers, thereby giving Ast
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2014 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

The Diversion of Controlled Substances and the Law
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comPharmacyPages.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415